The Bloomberg Terminal of fungi is raising.
FungiOS is the first unified intelligence platform for the $70B mycology economy. We're opening a Series A round to institutional investors and strategic partners.
The numbers speak.
A $70B industry with no data layer — until now.
Functional Mushrooms
Supplements, extracts, beverages
Culinary & Specialty
Fresh, dried, processed
Medicinal & Pharma
Psilocybin, beta-glucans, clinical
Mycotech & Materials
Packaging, construction, textiles
FungiOS sits at the intersection of all four segments as the intelligence and data layer — not a participant in any single vertical, but the infrastructure every participant depends on.
Three revenue streams. One platform.
SaaS Subscriptions
Tiered plans for individual cultivators, commercial operations, and research institutions. Monthly and annual billing.
Data Licensing
Anonymized aggregate data licensed to pharma companies, agritech firms, and market research organizations.
API & Integrations
Developer API for third-party apps, lab equipment integrations, and ERP connectors for commercial operations.
Multiple ways to participate.
Seed Investor
$50K – $250K- Pro rata rights in Series A
- Quarterly investor updates
- Early access to new modules
- Advisory board consideration
Series A Lead
$1M – $5M- Board observer seat
- Full pro rata rights
- Co-investment rights in future rounds
- Named partnership on platform
- Dedicated account management
- Custom data licensing terms
Strategic Partner
Non-dilutive- Data licensing agreement
- API integration partnership
- Co-marketing opportunities
- Research collaboration access
- Revenue share on referrals
Request the investor deck.
Fill out the form below and we'll send the full deck within 24 hours. All inquiries are treated with strict confidentiality.